We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00528996
First Posted: September 14, 2007
Last Update Posted: May 16, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Boehringer Ingelheim
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: No date given
  Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: April 30, 2014
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):